Philippe Jacques Wolgen, Chief Executive Officer & Managing Director at Clinuvel Pharmaceuticals Limited, holds 3.43M shares in Clinuvel Pharmaceuticals Limited (Ticker: CLVLF).
What is the percentage of profitable transactions made by Philippe Jacques Wolgen?
The percentage of profitable transactions made by Philippe Jacques Wolgen is 63%.
What is the average return per transaction made by Philippe Jacques Wolgen?
The average return per transaction made by Philippe Jacques Wolgen is 16.80%.
What stocks does Philippe Jacques Wolgen hold?
Philippe Jacques Wolgen holds: CLVLF stocks.
What was Philippe Jacques Wolgen’s latest transaction?
Philippe Jacques Wolgen latest transaction was an Uninformative Buy of ―.
What was Philippe Jacques Wolgen's most profitable transaction?
Philippe Jacques Wolgen’s most profitable transaction was an Informative Sell of CLVLF stock on July 5, 2021. The return on the trade was 55.80%.
What is Philippe Jacques Wolgen's role in Clinuvel Pharmaceuticals Limited?
Philippe Jacques Wolgen's role in Clinuvel Pharmaceuticals Limited is Chief Executive Officer & Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.